SABCS 2020: Adding Abemaciclib To Endocrine Therapy Improves Outcomes in High-Risk Early Breast Cancer
But longer follow-up of the monarchE trial is needed to confirm the findings
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.